109048 ⎘
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor; Recombinant DNA-technology; DNA or RNA fragments; Modified forms thereof Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides
5′ triphosphate oligonucleotide with blunt end and uses thereof
#8402NUCLEIC ACID CAPABLE OF INHIBITING EXPRESSION OF BETA-2GPI
#8403Materials and methods for modulation of tendon healing
#8404miR-122* as an active micro-RNA, compositions comprising the same and uses thereof
#8405Method of Treatment of Vascular Complications
#8406Compositions and methods for inhibition of expression of apolipoprotein C-III (APOC3) genes
#8407MicroRNA compounds and methods for modulating miR-21 activity
#8408Conditionally replicating adenovirus
#8409Anti-IL-23 antibodies
#8410METHODS
#8411Compositions and Methods for Yeast Extracellular Vesicles as Delivery Systems
#8412Small interfering RNAs with target-specific seed sequences
#8413METHODS AND COMPOSITIONS FOR PANIC DISORDERS
#8414Compositions and methods for treatment of prostate and other cancers
#8415Oligonucleotide-based inhibitors comprising locked nucleic acid motif
#8416Use of miRNA-214 inhibitor in inhibiting regulatory cells
#8417rAAV-based compositions and methods
#8418Sequence specific antimicrobials
#8419Recurrent gene fusions in prostate cancer
#8420MicroRNAs and uses thereof
#8421Compositions and methods of nucleic acid-targeting nucleic acids
#8422Non-coding RNA of and identification and use thereof
#8423Methods for treatment of alport syndrome
#8424Artificial match-type miRNA for controlling gene expression and use therefor
#8425Multiplex guide RNAs
#8426Multilayered nanoparticle and methods of manufacturing and using the same
#8427Sequence-specific inhibition of small RNA function
#8428FULLY STABILIZED ASYMMETRIC SIRNA
#8429METHODS OF IMPROVED PROTEIN PRODUCTION USING MIRNAs AND SIRNAs
#8430Regulation of BARD1 expression by non-coding RNA
#8431NOVEL FUSION GENES AS FACTORS RESPONSIBLE FOR GASTRIC CANCER
#8432DRG11-RESPONSIVE (DRAGON) GENE AND USES THEREOF
#8433Methods of determining eosinophilic gastritis status based on marker or gene expression
#8434Compositions and methods of nucleic acid-targeting nucleic acids
#8435Synthesis of transcripts using Syn5 RNA polymerase
#8436Methods of polynucleotide preparation using multivalent cation salt compositions
#8437Composition for regenerating normal tissue from fibrotic tissue
#8438Manganese ion coated nanoparticles for delivery of compositions into the central nervous system by nasal insufflation
#8439Inhibitor for inhibiting avian influenza virus and a pharmaceutical composition containing the same
#8440METHOD AND PHARMACEUTICAL COMPOSITION FOR INHIBITING NEURONAL REMODELING
#8441Hippo and dystrophin complex signaling in cardiomyocyte renewal
#8442SYSTEM FOR CO-DELIVERY OF POLYNUCLEOTIDES AND DRUGS INTO PROTEASE-EXPRESSING CELLS
#8443Modulation of huntingtin expression
#8444Dual Targeting siRNA Agents
#8445Agents and methods to elicit anti-tumor immune response
#8446METHODS FOR TREATING ALLERGIC AIRWAY INFLAMMATION
#8447Polypeptides, nucleic acids and uses thereof
#8448Nucleic acids encoding peptides for treating wounds, anti-angiogenic compounds and uses thereof
#8449Compositions and methods for treating and preventing neointimal stenosis
#8450Methods and pharmaceutical compositions for expressing a polynucleotide of interest in the retinal pigment epithelium of a subject
#8451Recombinant virus products and methods for inhibition of expression of myotilin
#8452TETRASPANIN CD82 AS A DIAGNOSTIC AND/OR THERAPEUTIC MODULE FOR XENOGRAFT RECOGNITION AND/OR REJECTION
#8453LIVER X RECEPTOR AGONISTS IN THE TREATMENT OF EMPHYSEMA
#8454Liposomal particles, methods of making same and uses thereof
#8455Markers for pre-cancer and cancer cells and the method to interfere with cell proliferation therein
#8456Nucleic acid inducing RNA interference modified for preventing off-target, and use thereof
#8457Immunotherapy of cancer
#8458Fractional regulation of transcription
#8459Compositions for modulating C9ORF72 expression
#8460Methods and compositions for the specific inhibition of transthyretin (TTR) by double-stranded RNA
#8461Materials and methods for treatment of pulmonary arterial hypertension
#8462Compositions of asymmetric interfering RNA and uses thereof
#8463SiRNA and their use in methods and compositions for inhibiting the expression of the FLAP gene
#8464Drug for Disease Caused by Expression of Periostin Except Eye Disease, and Use Thereof
#8465TOOLS AND METHODS USING MIRNA 182, 96 AND/OR 183 FOR TREATING PATHOLOGIES
#8466MEANS AND METHODS FOR COUNTERACTING MUSCLE DISORDERS
#8467Cationic lipid
#8468FORMULATIONS FOR INHIBITION OF pcsk9 FOR THE TREATMENT OF HYPERCHOLESTEROLEMIA
#8469METHOD FOR PREDICTING DEVELOPMENT OF MELANOMA BRAIN METASTASIS
#8470Plant regulatory elements and uses thereof
#8471Targeted augmentation of nuclear gene output
#8472PURIFICATION OF TRIPHOSPHORYLATED OLIGONUCLEOTIDES USING CAPTURE TAGS
#8473UCP1 (THERMOGENIN) - INDUCING AGENTS FOR USE IN THE TREATMENT OF A DISORDER OF THE ENERGY HOMEOSTASIS
#8474Haplotype Based Generalizable Allele Specific Silencing for Therapy of Cardiovascular Disease
#8475C/EBPα short activating RNA compositions and methods of use
#8476SnoRNA, compositions and uses
#8477EXON SKIPPING COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY
#8478Synergistic genome-nonintegrating reprogramming by microRNAs and transcription factors
#8479Pharmaceutical compositions comprising DENND1A variant 2 and methods of use thereof
#8480Methods and compositions for treating Huntington's disease
#8481MICRO-RNAS THAT MODULATE LYMPHANGIOGENESIS AND INFLAMMATORY PATHWAYS IN LYMPHATIC VESSEL CELLS
#8482Treatment of pyrroline-5-carboxylate reductase 1 (PYCR1) related disease by inhibition of natural antisense transcript to PYCR1
#8483Targeted integration into the PPP1R12C locus
#8484Plant regulatory elements and uses thereof
#8485METHOD FOR TRANSFORMATION OF STRAMENOPILE
#8486Use of IKK epsilon inhibitors to activate NFAT and T cell response
#8487USE OF MICRORNA 146-A IN THE DIAGNOSIS, TREATMENT AND PREVENTION OF PICORNAVIRUS INFECTION AND MICRORNA 146-A ANTAGONISTS
#8488APOB Antisense Conjugate Compounds
#8489Compositions and methods for inhibiting NF-κB and SOD-1 to treat amyotrophic lateral sclerosis
#8490Guide RNA with chemical modifications
#8491Methods and compositions for modifying a single stranded target nucleic acid
#8492Compositions and methods for treating cancer by rational targeting of protein translation
#8493Reversible platelet inhibition
#8494GENES OF AN OTITIS MEDIA ISOLATE OF NONTYPEABLE HEAMOPHILUS INFLUENZAE
#8495Method of producing infertile fish and egg-producing aquatic animals and of delivering compounds into eggs and embryos
#8496WHEAT WITH INCREASED NUMBER OF GRAINS AND METHOD FOR PRODUCING THE SAME, AND AGENT FOR INCREASING THE NUMBER OF WHEAT GRAINS
#8497Treatment of discs large homolog (DLG) related diseases by inhibition of natural antisense transcript to DLG
#8498Modulation of T cell signaling threshold and T cell sensitivity to antigens
#8499Quantification and spatio-temporal tracking of a target using a spherical nucleic acid (SNA)
#8500Molecular targets for selective eradication of senescent cells
#8501RNA INTERFERENCE SUPPRESSION OF NEURODEGENERATIVE DISEASES AND METHODS OF USE THEREOF
#8502MODULATION OF TIMP1 AND TIMP2 EXPRESSION
#8503MAGNETIC INORGANIC IRON-BASED NANOPARTICLES
#8504Multi-arm biodegradable polymers for nucleic acid delivery
#8505Treatment of colony-stimulating factor 3 (CSF3) related diseases by inhibition of natural antisene transcript to CSF3
#8506Compositions and methods for inhibiting gene expression of factor XII
#8507CHEMICALLY MODIFIED SHORT INTERFERING NUCLEIC ACID MOLECULES THAT MEDIATE RNA INTERFERENCE
#8508Methods and compositions employing an osteopontin aptamer to deliver nucleic acids into smooth muscle, endothelial, cardiac and progenitor/stem cells
#8509METHODS AND COMPOSITIONS FOR MODULATING GENE EXPRESSION USING COMPONENTS THAT SELF ASSEMBLE IN CELLS AND PRODUCE RNAI ACTIVITY
#8510Disulfide-containing alkyne linking agents
#8511RNA Interference Agents
#8512COMPOSITIONS AND METHODS FOR MODULATING AUTOPHAGIC CELL DEATH
#8513Targeting microRNA-26a/b for the treatment of neurodegenerative disease
#8514NUCLEIC ACID, PHARMACEUTICAL COMPOSITION AND USES THEREOF
#8515Method of using a miR172 Molecule for Decreasing Inflammation
#8516Dual Peptide-Mediated Targeted Delivery System
#8517COMPOSITIONS AND METHODS RELATING TO C5L2
#8518Nucleic acid silencing sequences
#8519RNA POLYMERASE II215 NUCLEIC ACID MOLECULES TO CONTROL INSECT PESTS
#8520Methods and compositions for multiplex RNA guided genome editing and other RNA technologies
#8521Use of microRNA precursors as drugs for inducing CD34-positive adult stem cell expansion
#8522MODIFIED iRNA AGENTS
#8523OLIGONUCLEOTIDE COMPRISING AN INOSINE FOR TREATING DMD
#8524Compositions and methods for inhibiting expression of the LECT2 gene
#8525RNA targeting in alpha-synucleinopathies
#8526RNA interference mediated inhibition of gene expression using short interfering nucleic acids (siNA)
#8527Compositions and Methods for Inhibiting Expression of Transthyretin
#8528MICRONEEDLE ARRAYS FOR ACTIVE AGENT DELIVERY
#8529Suicide contrast agents targeting HIV reservoirs for theranostic eradication
#8530METHODS OF CONTROLLING VASCULARITY USING RAVER2 AS A MEDIATOR FOR EXPRESSION OF VEGF RECEPTOR SFIT1
#8531Method to trigger RNA interference
#8532MCPIP protection against osteoclast production
#8533METHODS AND COMPOSITIONS FOR TREATMENT OF ANGELMAN SYNDROME AND AUTISM SPECTRUM DISORDERS
#8534Interfering RNA delivery system and uses thereof
#8535Methods for inducing cardiomyocyte proliferation
#8536SERPINC1 iRNA COMPOSITIONS AND METHODS OF USE THEREOF
#8537COSTIMULATORY B7-H1 IN RENAL CELL CARCINOMA PATIENTS: INDICATOR OF TUMOR AGGRESSIVENESS AND POTENTIAL THERAPEUTIC TARGET
#8538Identification of structurally similar small molecules that enhance therapeutic exon skipping
#8539Cationic lipid
#8540REGULATION OF NPVF GENE AND ITS PRODUCTS: A METHOD FOR MODULATING ENERGY IMBALANCE
#8541Block copolymers and uses thereof
#8542Sterically stabilized cationic nanocarrier, kits and method of use
#8543Modulation of MRTF-A activity in pathologic fibrosis and wound healing
#8544METHODS AND COMPOSITIONS FOR LOCALIZED AGENT DELIVERY
#8545Sugarcane bacilliform viral (SCBV) enhancer and its use in plant functional genomics
#8546Mutant calreticulin for the diagnosis of myeloid malignancies
#8547MicroRNA PROFILES IN HEART FAILURE: METHODS AND SYSTEMS FOR DETECTION AND USE
#8548Non-liposomal systems for nucleic acid delivery
#8549Soybean U6 polymerase III promoter and methods of use
#8550Treating hepatitis virus infection by modulating microRNAs miR-130a, miR-130b, miR-204, or miR-1236
#8551MicroRNA-Based Methods and Compositions for the Diagnosis, Prognosis and Treatment of Breast Cancer
#8552MODULATION OF EXON RECOGNITION IN PRE-MRNA BY INTERFERING WITH THE SECONDARY RNA STRUCTURE
#8553MicroRNA compounds and methods for modulating miR-122
#8554MicroRNAs modulating the effect of glucocorticoid signaling
#8555Compositions for modulating C9ORF72 expression
#8556Short hairpin RNA compositions, methods of making and applications thereof
#8557THERAPEUTIC COMPOUNDS
#8558Functional genomics using CRISPR-Cas systems, compositions, methods, screens and applications thereof
#8559Compositions and methods of nucleic acid-targeting nucleic acids
#8560Costimulatory B7-H1 in renal cell carcinoma patients: indicator of tumor aggressiveness and potential therapeutic target
#8561UK-2 biosynthetic gene and method for improving UK-2 productivity using the same
#8562Reduced size self-delivering RNAI compounds
#8563Complement component C5 iRNA compositions and methods of use thereof
#8564Reducing intron retention
#8565Lipid particles with asymmetric cationic lipids for RNA delivery
#8566RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
#8567COMPOSITIONS AND TREATMENTS BASED ON CADHERIN MODULATION
#8568TARGETING GLIOMA STEM CELLS BY SEQUENCE-SPECIFIC FUNCTIONAL INHIBITION OF PRO-SURVIVAL ONCOMIR-138
#8569Compositions and methods for modulating neuronal excitability and motor behavior
#8570Formats for organic compounds for use in RNA interference
#8571TREATING DISEASES ASSOCIATED WITH PGC1-ALPHA BY MODULATING MICRORNAS MIR-130A AND MIR-130B
#8572Microrna inhibition for the treatment of inflammation and myeloproliferative disorders
#8573MicroRNA compounds and methods for modulating miR-21 activity
#8574Serpina1 siRNAs: compositions of matter and methods of treatment
#8575Bioactive renal cells
#8576HCBI sequences as an early marker for the future development of cancer and diseases of the CNS and as a target for cancer treatment and prevention
#8577Nucleic acid-lipopolymer compositions
#8578THERAPEUTIC USES OF MICROVESICLES AND RELATED MICRORNAS
#8579RNY-derived small RNAs as biomarkers for atherosclerosis-related disorders
#8580Modeling and Predicting Differential Alternative Splicing Events and Applications Thereof
#8581RNA-guided transcriptional regulation
#8582Transgenic Plants With Enhanced Traits
#8583Methods and compositions for the specific inhibition of complement component 5(C5) by double-stranded RNA
#8584Modulation of apolipoprotein C-III expression
#8585Method for the inhibition of angiogenesis
#8586METHODS FOR MODULATING EXPRESSION OF C9ORF72 ANTISENSE TRANSCRIPT
#8587Inhibitors of CACNA1A/ALPHA1A subunit internal ribosomal entry site (IRES) and methods of treating spinocerebellar ataxia type 6
#8588ALLELE-SPECIFIC RNA SILENCING FOR THE TREATMENT OF HYPERTROPHIC CARDIOMYOPATHY
#8589Compounds for inducing anti-tumor immunity and methods thereof
#8590Methods and compositions to inhibit metastasis and to treat fibrosis and to enhance wound healing
#8591Tau antisense oligomers and uses thereof
#8592Peptide oligonucleotide conjugates
#8593Pri-mirna libraries and methods for making and using pri-mirna libraries
#8594Stem cell microparticles and miRNA
#8595COMPOSITIONS AND METHODS FOR CONTROLLING DIABROTICA
#8596COMPOSITIONS AND METHODS FOR CONTROLLING DIABROTICA
#8597COMPOSITIONS FOR MODULATING EXPRESSION OF C9ORF72 ANTISENSE TRANSCRIPT
#8598Methods for inducing glucose uptake
#8599siRNA sequence-independent modification formats for reducing off-target phenotypic effects in RNAI, and stabilized forms thereof
#8600RNA INTERFERENCE SUPPRESSION OF NEURODEGENERATIVE DISEASES AND METHODS OF USE THEREOF
#8601ALPHA HELIX CELL-PENETRATING PEPTIDE MULTIMER, PREPARATION METHOD THEREFOR AND USE THEREFOR
#8602POTENT LNA OLIGONUCLEOTIDES FOR THE INHIBITION OF HIF-1A EXPRESSION
#8603Non-enzymatic, salt-mediated synthesis of polynucleic acids
#8604Hypoxia-Targeted Delivery System for Pharmaceutical Agents
#8605Biological control of insects
#8606Orthogonal Cas9 proteins for RNA-guided gene regulation and editing
#8607Nuclear targeting sequences
#8608Parental RNAi suppression of chromatin remodeling genes to control coleopteran pests
#8609PARENTAL RNAI SUPPRESSION OF HUNCHBACK GENE TO CONTROL COLEOPTERAN PESTS
#8610Compositions and methods for treating amyotrophic lateral sclerosis
#8611Anti-tumor therapy
#8612NUCLEIC ACID MOLECULE FOR INHIBITING ACTIVITY OF RNAI MOLECULE
#8613Compositions and methods related to miRNA modulation of neovascularization or angiogenesis
#8614Compositions for targeted delivery of siRNA
#8615Antisense compositions and methods of making and using same
#8616Gene expression and pain
#8617Single-stranded RNAi agents containing an internal, non-nucleic acid spacer
#8618NOVEL LINCRNA AND INTERFERING NUCLEIC ACID MOLECULES, COMPOSITIONS AND METHODS AND USES THEREOF FOR REGULATING ANGIOGENESIS AND RELATED CONDITIONS
#8619Identification of small molecules that facilitate therapeutic exon skipping
#8620Use of novel monosaccharide-like glycylated sugar alcohol compositions for designing and developing anti-diabetic drugs
#8621Methods for Diagnosing Prostate Cancer Using MicroRNAs
#8622UNA OLIGOMER ACTIVE STRUCTURES FOR THERAPEUTIC AGENTS
#8623THERAPEUTIC COMPOSITIONS AND METHODS FOR MALIGNANT TUMORS WITH RNAI MOLECULES TARGETED TO HSP47 AND P21
#8624Methods of modulating compliance of the trabecular meshwork
#8625Compositions and methods for treating lung disease and injury
#8626Chemically ligated RNAs for CRISPR/Cas9-lgRNA complexes as antiviral therapeutic agents
#8627METHODS FOR MODULATING IMMUNE RESPONSES DURING CHRONIC IMMUNE CONDITIONS BY TARGETING METALLOTHIONEINS
#8628Ph-sensitive peptides and their nanoparticles for drug delivery
#8629Novel Delivery Compositions and Methods of Using Same
#8630Switchable Cas9 nucleases and uses thereof
#8631Genetic inhibition by double-stranded RNA
#8632Methods and means for treatment of osteoarthritis
#8633RNA interference agents for GST-PI gene modulation
#8634Targeting microRNAs for metabolic disorders
#8635miR-92 inhibitors and uses thereof
#8636AAV-based treatment of cholesterol-related disorders
#8637RNA interference agents for P21 gene modulation
#8638RNA agents for P21 gene modulation
#8639RNA agents for GST-Pi gene modulation
#8640PARENTAL RNAI SUPPRESSION OF KRUPPEL GENE TO CONTROL COLEOPTERAN PESTS
#8641Parental RNAI suppression of hunchback gene to control hemipteran pests
#8642Parental RNAi suppression of chromatin remodeling genes to control coleopteran pests
#8643Therapeutic agent for corneal epithelial disorder
#8644Compositions and Methods for Inducing Senescence in Cancer Cells
#8645Neurocalcin delta inhibitors and therapeutic and non-therapeutic uses thereof
#8646METHODS OF USE OF SPHINGOLIPID POLYALKYLAMINE OLIGONUCLEOTIDE COMPOUNDS
#8647COMPOSITIONS AND METHODS FOR TREATING A HEMATOLOGICAL MALIGNANCY ASSOCIATED WITH AN ALTERED RUNX1 ACTIVITY OR EXPRESSION
#8648RNA/DNA nanoparticle for siRNA target-specific delivery and vehicle including the same
#8649Modulation of KCNH2 isoform expression by oligonucleotides as a therapeutic approach for long QT syndrome
#8650USE OF NUCLEIC ACIDS WITH REDUCED PRESSURE THERAPY
#8651Block copolymers
#8652Hydrogels for delivery of therapeutic compounds
#8653Tyrosine-based lipids for delivery of therapeutics
#8654Acellular pro-inflammatory compositions, process for making same and methods of using same
#8655Method of treating pain with an antibody against netrin-4, Unc5B or neogenin
#8656Methods and compositions for selecting siRNA of improved functionality
#8657Antisense RNA for treating cancer and inhibition of metastasis and vectors for antisense sequestration
#8658Methods and compositions for selecting siRNA of improved functionality
#8659SPARC (secreted protein, acidic and rich in cysteine), a new target for the treatment and prevention of acute liver failure
#8660Micro-RNA regulation of bone loss
#8661Methods, systems, and compositions relating to miRNA-146a
#8662COMPOSITIONS AND METHODS FOR TREATING ANAPLASTIC THYROID CANCER
#8663Development of novel macromolecule transduction domain with improved cell permeability and method for using same
#8664Compounds compositions and methods including thermally labile moieties
#8665Lipids and compositions for the delivery of therapeutics
#8666METHODS OF MODULATING THE NEGATIVE CHEMOTAXIS OF IMMUNE CELLS
#8667Biomolecular group related to cell anti-aging
#8668Structuring fats and methods of producing structuring fats
#8669NUCAMPHOLIN NUCLEIC ACID MOLECULES TO CONTROL COLEOPTERAN INSECT PESTS
#8670Methods and compositions for selecting siRNA of improved functionality
#8671DESIGN AND CONSTRUCTION OF BIFUNCTIONAL SHORT HAIRPIN RNA
#8672INHIBITING CANCER METASTASIS
#8673Compounds and methods for modulating target nuclear and sub-nuclear nucleic acid molecules in cells and animals
#8674Compounds and methods for modulating target nuclear and sub-nuclear nucleic acid molecules in cells and animals
#8675MODULATION OF EXON RECOGNITION IN PRE-MRNA BY INTERFERING WITH THE SECONDARY RNA STRUCTURE
#8676Method of enhancing miR-185 expression to reduce low density lipoprotein/cholesterol accumulation in a cell
#8677Methods for treating and/or limiting development of diabetes
#8678Lipid formulated compositions and methods for inhibiting expression of serum amyloid A gene
#8679Targeting non-coding RNA for RNA interference
#8680Methods for Modulation of Autophagy Through the Modulation of Autophagy-Inhibiting Gene Products
#8681Modulation of γδ T cells
#8682APPLICATIONS OF AN IMMUNE SYSTEM-RELEASED ACTIVATING AGENT (ISRAA)
#8683NEW CELL-SPECIFICALLY ACTIVE NUCLEOTIDE MOLECULES AND APPLICATION KIT FOR THE APPLICATION THEREOF
#8684Antisense oligonucleotides with improved pharmacokinetic properties
#8685Methods for treating and/or limiting development of diabetes
#8686Methods and compositions for selecting siRNA of improved functionality
#8687RAAV-based compositions and methods for treating alpha-1 anti-trypsin deficiencies
#8688RECOMBINANT CELLS AND METHODS OF USING SUCH CELLS TO IDENTIFY CIRCADIAN RHYTHM MODULATORS
#8689GHO/SEC24B2 AND SEC24B1 NUCLEIC ACID MOLECULES TO CONTROL COLEOPTERAN AND HEMIPTERAN PESTS
#8690Modified nucleosides, analogs thereof and oligomeric compounds prepared therefrom
#8691Methods and Compositions for the Treatment of Prostate Related Disorders using miR-1
#8692Methods and compositions for treating malignant tumors associated with KRAS mutation
#8693RNA interference compositions and methods for malignant tumors
#8694Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof
#8695Methods and compositions for modulating gene expression using oligonucleotide based drugs administered in vivo or in vitro
#8696Methods for Diagnosing Lung Cancer Using MicroRNAs
#8697Methods and compositions for the specific inhibition of beta-catenin by double-stranded RNA
#8698Bicyclic morpholino compounds and oligomeric compounds prepared therefrom
#8699SUBSTITUTED MORPHOLINO COMPOUNDS ANALOGS THEREOF AND OLIGOMERIC COMPOUNDS PREPARED THEREFROM
#8700C-myc antisense oligonucleotides and methods for using the same to treat cell-proliferative disorders